LCN2 and endometrial cancer: The objectives of the study are the following: to examine the behavior of MMP-9 and NGAL levels in patients with endometrial cancer and benign endometrial disorders and to assess the relationship between the serum levels of MMP-9 and NGAL and the clinical staging and histopathological grade of the tumor.